7-hydroxystaurosporine has been researched along with warfarin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Kobayashi, S; Kurata, N; Matsushita, S; Nishi, K; Otagiri, M; Suenaga, A; Watanabe, HH | 1 |
Cory, JG; Somerville, L | 1 |
3 other study(ies) available for 7-hydroxystaurosporine and warfarin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Characterization of a binding site of UCN-01, a novel anticancer drug on alpha-acid glycoprotein.
Topics: Alkaloids; Antineoplastic Agents; Binding, Competitive; Orosomucoid; Progesterone; Propranolol; Staurosporine; Ultracentrifugation; Warfarin | 2000 |
Altered sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to apoptosis induced by 7-hydroxystaurosporine.
Topics: Alkaloids; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Cathepsins; CDC2 Protein Kinase; Cell Cycle; Coumarins; Cyclin B; Cyclin B1; Cysteine Proteinase Inhibitors; Cytochrome c Group; Deoxyadenosines; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Flow Cytometry; Leukemia L1210; Mice; Oligopeptides; Protein Kinase C; Sensitivity and Specificity; Staurosporine; Tumor Cells, Cultured | 2000 |